Table 2.

Patient′s diagnosis and procedures

Physiology	Diagnosis	Procedures
SV s/p stage I (2.3%)	HLHS/HLHC (n=1)	Branch PA stenting (n=1).
SV s/p stage II (34.1%)	HLHS / HLHC (n=9) AVSD dysbalance (n=3) DILV (n=3)	Branch PA intervention (n=18). SVC stenting (n=1). Venous collateral closure (n=7).
BV (63.6%)	IVC anomaly, or inappropriate vascular calibre of femoral/iliacal vessels (n=12)	PPVI (n=7). ASD device closure (n=3). IVC stenting (n=1). Branch PA stenting (n=2). BAP pulmonary vein stenosis (n=2).
	SVC syndrome (n=3)	SVC stenting (n=3).
	Pulmonary atresia (n=2)	PDA stenting (n=4).
	Aortic arch hypoplasia (n=2)	Aortic arch stenting (n=2).
	TAPVD with obstruction (n=3)	Vertical vein stenting (n=2). Venous duct stenting (n=2).
	Miscellaneous: PAPVD (n=1) SCT (n=2) mVSD (n=1) ECMO (n=1) Pulmonary vein stenosis (n=1)	Vertical vein closure (n=1). Coiling of feeding arteries (n=2). VSD closure (n=1). Placement cannula (n=1). Diagnostic (n=1)/BAP pulmonary vein stenosis (n=2).

ASD, atrial septal defect; AVSD, atrioventricular septal defect; BAP, balloon angioplasty; BV, biventricular heart; DILV, double inlet left ventricle; ECMO, extracorporeal membrane oxygenation; HLHS/HLHC, hypoplastic left heart syndrome/complex; IVC, inferior vena cava; mVSD, muscular ventricular septal defect; PA, pulmonary artery; PAPVD, partial anomalous pulmonary venous drainage; PDA, patent ductus arteriosus; PPVI, percutaneous pulmonary valve implantation; SCT, sacrococcygeal teratoma; SV, single ventricle; SVC, superior vena cava; TAPVD, total anomalous pulmonary venous drainage; VSD, ventricular septal defect.